Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expression
- 18 September 2007
- Vol. 61 (12) , 991-1001
- https://doi.org/10.1002/syn.20456
Abstract
Genetic variability in the α‐synuclein gene and long‐term exposure to the pesticide paraquat constitute possible risk factors for sporadic Parkinson's disease. The goal of the present study was to further characterize the effects of paraquat in mice as a model of Parkinson's disease and to determine whether it acted synergistically with α‐synuclein over‐expression to cause nigrostriatal cell death or dysfunction. Paraquat (10 mg/kg i.p.) was administered once a week for 3 weeks to mice over‐expressing human α‐synuclein under the Thy1 promoter and their wild‐type littermates. The effect of paraquat on catecholaminergic neurons was reminiscent of that of Parkinson's disease, with preferential loss of dopaminergic neurons in the ventral tier of the substantia nigra pars compacta and loss of tyrosine hydroxylase staining in the locus coeruleus. α‐Synuclein over‐expression did not increase paraquat‐induced cell loss, and paraquat did not worsen the behavioral deficits observed in the transgenic mice. However, paraquat markedly increased proteinase‐K‐resistant α‐synuclein aggregates in substantia nigra of the transgenic mice. The data further validate the use of paraquat to model Parkinson's disease in mice and show that although paraquat and α‐synuclein over‐expression act synergistically to increase protein aggregation in vivo, this interaction does not result in short‐term neuroprotection or increased vulnerability of nigrostriatal neurons. Synapse 61:991–1001, 2007.Keywords
This publication has 54 references indexed in Scilit:
- Pesticide Exposure Exacerbates α-Synucleinopathy in an A53T Transgenic Mouse ModelThe American Journal of Pathology, 2007
- Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degenerationNeurobiology of Disease, 2006
- Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synucleinNeuroscience, 2006
- Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug DiscoveryNeuron, 2006
- α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson diseaseNature Neuroscience, 2005
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promotersJournal of Neuroscience Research, 2002
- Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's diseaseFEBS Letters, 2001
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Antidromic identification of dopaminergic and other output neurons of the rat substantia nigraBrain Research, 1978